A. Klein et al., Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair, LEUKEMIA, 14(1), 2000, pp. 40-46
B cell chronic lymphocytic leukemia (B-CLL) cannot be cured with convention
al chemotherapy, This clinical enigma appears to be at least partially due
to the fact that B-CLL cells are resistant to programmed cell death (apopto
sis) and that they are arrested in G0/G1 phase of the cell cycle. The reaso
ns for the dysregulation of these two key cellular events in B-CLL are uncl
ear. The present study aimed at determining correlations between the expres
sion levels of proteins regulating apoptosis, cell cycle and DNA repair in
B-CLL cells and normal B cells. In addition, the differential sensitivity o
f B-CLL cells to drug-induced apoptosis was quantified. We show that in B-C
LL cells levels of the death-suppressor Bcl-2 correlated positively with th
ose of the pro-apoptotic protein Bar and of the cyclin-dependent kinase (cd
k) inhibitor p27(Kip1). I, B-CLL cells levels of the anti-apoptotic Bcl-x(L
) showed a positive correlation with levels of the 80 kDa regulatory compon
ent (Ku80) of the DNA-dependent protein kinase that is involved in DNA doub
le-stranded break repair. These correlations were not detected in normal B
cells. The sensitivity of leukemic cells to FLUD but not to ADM, CPM or to
DEX was reduced in pre-treated patients. These data support the hypothesis
that in B-CLL cells death-modulators and molecules modulating cell cycle an
d DNA repair are regulated in a coordinated manner.